125 related articles for article (PubMed ID: 8959993)
21. [Calcium ion is a common denominator in the pathophysiological processes of amyotrophic lateral sclerosis].
Patai R; Nógrádi B; Meszlényi V; Obál I; Engelhardt J; Siklós L
Ideggyogy Sz; 2017 Jul; 70(7-8):247-257. PubMed ID: 29870639
[TBL] [Abstract][Full Text] [Related]
22. Differential effect of oxidative or excitotoxic stress on the transcriptional profile of amyotrophic lateral sclerosis-linked mutant SOD1 cultured neurons.
Boutahar N; Wierinckx A; Camdessanche JP; Antoine JC; Reynaud E; Lassabliere F; Lachuer J; Borg J
J Neurosci Res; 2011 Sep; 89(9):1439-50. PubMed ID: 21647936
[TBL] [Abstract][Full Text] [Related]
23. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.
Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C
Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555
[TBL] [Abstract][Full Text] [Related]
24. Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice.
Staats KA; Van Helleputte L; Jones AR; Bento-Abreu A; Van Hoecke A; Shatunov A; Simpson CL; Lemmens R; Jaspers T; Fukami K; Nakamura Y; Brown RH; Van Damme P; Liston A; Robberecht W; Al-Chalabi A; Van Den Bosch L
Neurobiol Dis; 2013 Dec; 60():11-7. PubMed ID: 23969236
[TBL] [Abstract][Full Text] [Related]
25. Excitotoxicity in ALS: Overstimulation, or overreaction?
King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2016 Jan; 275 Pt 1():162-71. PubMed ID: 26584004
[TBL] [Abstract][Full Text] [Related]
26. Protein SUMOylation, an emerging pathway in amyotrophic lateral sclerosis.
Dangoumau A; Veyrat-Durebex C; Blasco H; Praline J; Corcia P; Andres CR; Vourc'h P
Int J Neurosci; 2013 Jun; 123(6):366-74. PubMed ID: 23289752
[TBL] [Abstract][Full Text] [Related]
27. Amyotrophic lateral sclerosis: is excitotoxicity the key?
Krueger G
CMAJ; 1994 Aug; 151(4):441-3. PubMed ID: 8055404
[No Abstract] [Full Text] [Related]
28. Dorfin-CHIP chimeric proteins potently ubiquitylate and degrade familial ALS-related mutant SOD1 proteins and reduce their cellular toxicity.
Ishigaki S; Niwa J; Yamada S; Takahashi M; Ito T; Sone J; Doyu M; Urano F; Sobue G
Neurobiol Dis; 2007 Feb; 25(2):331-41. PubMed ID: 17157513
[TBL] [Abstract][Full Text] [Related]
29. Regulation of system x(c)- in the SOD1-G93A mouse model of ALS.
Albano R; Liu X; Lobner D
Exp Neurol; 2013 Dec; 250():69-73. PubMed ID: 24041987
[TBL] [Abstract][Full Text] [Related]
30. Decreased striatal dopamine-receptor binding in sporadic ALS: glutamate hyperactivity?
Vogels OJ; Oyen WJ; van Engelen BG; Padberg GW; Horstink MW
Neurology; 1999 Apr; 52(6):1275-7. PubMed ID: 10214758
[TBL] [Abstract][Full Text] [Related]
31. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
32. Excitotoxicity and amyotrophic lateral sclerosis.
Van Damme P; Dewil M; Robberecht W; Van Den Bosch L
Neurodegener Dis; 2005; 2(3-4):147-59. PubMed ID: 16909020
[TBL] [Abstract][Full Text] [Related]
33. Animal models of BMAA neurotoxicity: a critical review.
Karamyan VT; Speth RC
Life Sci; 2008 Jan; 82(5-6):233-46. PubMed ID: 18191417
[TBL] [Abstract][Full Text] [Related]
34. Neurodegenerative disease. Guam's deadly stalker: on the loose worldwide?
Miller G
Science; 2006 Jul; 313(5786):428-31. PubMed ID: 16873621
[No Abstract] [Full Text] [Related]
35. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis.
Van Den Bosch L; Van Damme P; Bogaert E; Robberecht W
Biochim Biophys Acta; 2006; 1762(11-12):1068-82. PubMed ID: 16806844
[TBL] [Abstract][Full Text] [Related]
36. Calcium: the Darth Vader of ALS.
Appel SH; Beers D; Siklos L; Engelhardt JI; Mosier DR
Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Mar; 2 Suppl 1():S47-54. PubMed ID: 11465925
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis.
Drachman DB; Rothstein JD
Ann Neurol; 2000 Nov; 48(5):792-5. PubMed ID: 11079544
[TBL] [Abstract][Full Text] [Related]
38. Amyotrophic lateral sclerosis: what makes the direct corticospinal tract so vulnerable.
Kaji R; Kimura J
Muscle Nerve; 1993 Aug; 16(8):872-4. PubMed ID: 8101353
[No Abstract] [Full Text] [Related]
39. Amyotrophic lateral sclerosis: new insights into underlying molecular mechanisms and opportunities for therapeutic intervention.
Cozzolino M; Pesaresi MG; Gerbino V; Grosskreutz J; Carrì MT
Antioxid Redox Signal; 2012 Nov; 17(9):1277-330. PubMed ID: 22413952
[TBL] [Abstract][Full Text] [Related]
40. Serotonergic mechanisms in amyotrophic lateral sclerosis.
Sandyk R
Int J Neurosci; 2006 Jul; 116(7):775-826. PubMed ID: 16861147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
